Trexquant Investment LP Anavex Life Sciences Corp. Transaction History
Trexquant Investment LP
- $4.86 Billion
- Q1 2024
A detailed history of Trexquant Investment LP transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Trexquant Investment LP holds 83,185 shares of AVXL stock, worth $342,722. This represents 0.01% of its overall portfolio holdings.
Number of Shares
83,185
Previous 57,655
44.28%
Holding current value
$342,722
Previous $536,000
21.08%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding AVXL
# of Institutions
159Shares Held
31.6MCall Options Held
910KPut Options Held
1.35M-
State Street Corp Boston, MA7.3MShares$30.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$27.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$18.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$7.06 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC851KShares$3.51 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $321M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...